treatment efficacyup to 6 months (5‐12 weeks) · depression in adults
Behavioural activation probably leads to higher treatment efficacyup to 6 months (5‐12 weeks) compared with treatment (moderate certainty).
1 finding from 1 review
treatment acceptabilityup to 6 months (5‐12 weeks) · depression in adults
Behavioural activation showed no clear difference in treatment acceptabilityup to 6 months (5‐12 weeks) compared with treatment (moderate certainty).
1 finding from 1 review
depression symptoms (continuous) up to 6 months (4‐8 weeks) · depression in adults
1 finding from 1 review
quality of life (continuous)up to 6 months (2 weeks) · depression in adults
1 finding from 1 review
social adjustment and functioning (continuous)up to 6 months (12 weeks) · depression in adults
1 finding from 1 review
Anxiety · depression in adults
1 finding from 1 review
adverse events(8‐10 weeks) · depression in adults
1 finding from 1 review
social adjustment and functioning (continuous)up to 6 months (12 weeks) · depression in adults
1 finding from 1 review
Anxiety · depression in adults
1 finding from 1 review
adverse events (16 weeks) · depression in adults
1 finding from 1 review
treatment efficacy up to 6 months (4‐8 weeks) · depression in adults
Behavioural activation showed no clear difference in treatment efficacy up to 6 months (4‐8 weeks) compared with third‐wave CBT (low certainty).
1 finding from 1 review
Secondary outcome: acceptability of treatment · depression in adults
Behavioural activation showed no clear difference in treatment acceptability up to 6 months (4‐8 weeks) compared with third‐wave CBT (low certainty).
1 finding from 1 review
Treatment efficacy for depression (short term: 8–9 weeks) · depression in adults with non‐communicable diseases
Behavioural activation showed no clear difference in treatment efficacy for depression (short term: 8–9 weeks) compared with any comparator (low certainty).
1 finding from 1 review
Quality of life (medium term: 12 months) · depression in adults with non‐communicable diseases
1 finding from 1 review
Social adjustment and functioning (medium term: 12 months) · depression in adults with non‐communicable diseases
2 findings from 1 review
Improvement in anxiety symptoms (medium term: 12 months) · depression in adults with non‐communicable diseases
2 findings from 1 review
Treatment efficacy for depression (medium term: 12 months) · depression in adults with non‐communicable diseases
Behavioural activation probably leads to higher treatment efficacy for depression (medium term: 12 months) compared with any comparator (moderate certainty).
1 finding from 1 review
Treatment efficacy for depression (long term: 24 months) · depression in adults with non‐communicable diseases
Behavioural activation showed no clear difference in treatment efficacy for depression (long term: 24 months) compared with any comparator (moderate certainty).
1 finding from 1 review
Acceptability · depression in adults with non‐communicable diseases
Behavioural activation showed no clear difference in treatment acceptability (short term: 2 months) compared with any comparator (low certainty).
2 findings from 1 review
Improvement in depression symptoms (short term: 5–6 months) · depression in adults with non‐communicable diseases
1 finding from 1 review